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OBJECTIVES The goal of this study was to examine the cross-sectional associations of cardiovascular risk
factors with left ventricular (LV) geometry and systolic function measured by cardiac
magnetic resonance imaging (MRI) in the Multiethnic Study of Atherosclerosis (MESA).
BACKGROUND Cardiovascular risk factors including hypertension, smoking, and obesity are known to be
associated with increased LV mass, but less is known about the association of risk factors with
LV systolic function, particularly in populations without clinical cardiovascular disease.
METHODS Participants were from 4 racial/ethnic groups and were free of clinical cardiovascular disease.
Blood pressure, health habits, body mass index, lipid levels, and glucose abnormalities were
assessed and MRI exams performed at baseline (n  4,869). Multivariable linear regression
was used to model the association of risk factors with LV mass, end-diastolic volume, stroke
volume, ejection fraction, and cardiac output.
RESULTS The mean age was 62 years, and 52% of the participants were women. After adjustment for
sociodemographic variables and height, higher systolic blood pressure and body mass index
were associated with larger LV mass and volumes. Current smoking and diabetes were
associated with greater LV mass (7.7 g, 95% confidence interval [CI] 5.5 to 9.9 and
3.5 g, 95% CI 1.2 to 5.8, respectively), and with lower stroke volume (1.9 ml, 95%
CI 3.3 to 0.5 and 4.5 ml, 95% CI 6.0 to 3.0, respectively) and lower ejection
fraction (1.6%, 95% CI 2.1 to 1.0 and 0.8%, 95% CI 1.5 to 0.2, respectively).
CONCLUSIONS In this cohort free of clinical cardiovascular disease, modifiable risk factors were associated
with subclinical alterations in LV size and systolic function as detected by cardiac
MRI. (J Am Coll Cardiol 2006;48:2285–92) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.03.072Cardiology Foundation
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darge epidemiologic studies of left ventricular (LV) geom-
try and systolic function have generally relied upon echo-
ardiography (1–3). High systolic blood pressure, smoking,
nd obesity have been consistently associated with elevated
V mass, but less information is available about the asso-
iation of traditional cardiovascular risk factors with LV
ystolic function, particularly in asymptomatic populations.
agnetic resonance imaging (MRI) of the heart provides
ccurate and reproducible measurement of LV mass, vol-
mes, and systolic function (4), is not limited by acoustic
indows as is echocardiography, does not rely on geometric
ssumptions about the shape of the ventricle, and does not
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006, accepted March 30, 2006.equire exposure to ionizing radiation. Thus, MRI is an
ppropriate noninvasive technology for investigating sub-
linical alterations in LV size and systolic function.
The Multiethnic Study of Atherosclerosis (MESA) is the
rst large-scale application of cardiac MRI in a multicenter
tudy and in a multiethnic population. Most previous
tudies of cardiac MRI have been limited by the inclusion of
mall numbers of participants, a focus on patients with
re-existing cardiovascular disease, or incomplete informa-
ion on risk factors. We used data from the baseline
xamination in the MESA to examine the cross-sectional
elationships of traditional cardiovascular risk factors with 5
RI measurements—LV mass, end-diastolic volume,
troke volume, ejection fraction, and cardiac output—in
eople without clinical cardiovascular disease.
ETHODS
etting. The MESA was designed to investigate the
athogenesis of atherosclerosis in 4 racial/ethnic groups by
roviding accurate measurement of early cardiovascular
isease and its progression. Between July 2000 and Septem-
er 2002, 6,814 men and women aged 45 to 84 years were
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Cardiovascular Risk Factors and Cardiac MRI December 5, 2006:2285–92nrolled from 6 U.S. communities (5,6). Potential partici-
ants were contacted by random digit dialing or by infor-
ational brochures mailed to households identified by
ampling frames such as census data or by geographic
riteria. Institutional review boards at all study centers
pproved the study protocol, and informed consent was
btained from every participant. Participants were recruited
rom 4 ethnic groups: white, African American, Hispanic,
nd Asian (of Chinese descent); race and ethnicity were
elf-reported. All participants were free of clinically recog-
ized cardiovascular disease at enrollment.
aseline examination. Participants underwent an exten-
ive baseline evaluation, including measurement of height,
eight, and waist circumference, and assessment by ques-
ionnaire of smoking, alcohol intake, educational attain-
ent, exercise (including team sports, dance, moderate
ndividual activities or conditioning, vigorous dual sports or
onditioning, and walking for exercise), current medica-
ions, and physician diagnoses of hypertension and diabetes
5). Blood pressure was measured 3 times in the seated
osition with a Dinamap device (Critikon, Tampa, Florida)
7); the mean of the second and third measurements was
sed in the analysis. Heart rate was monitored and recorded
t the time of the MRI exam. Glucose, triglycerides, and
otal and high-density lipoprotein (HDL) cholesterol levels
ere measured after a 12-h fast, and low-density lipoprotein
LDL) cholesterol level was calculated with the Friedewald
quation (8).
agnetic resonance imaging. Consenting participants
nderwent a cardiac MRI scan a median of 16 days after the
aseline evaluation; 95% were completed by 11 weeks after
he baseline examination. Participation in the MRI exam
as voluntary. The MRI exams were performed using
canners with 1.5-T magnets as previously described (9). All
maging was performed with a 4-element phased-array
urface coil positioned anteriorly and posteriorly, electrocar-
iographic gating, and brachial artery blood pressure mon-
toring. Imaging consisted of fast gradient echo cine images
f the left ventricle with time resolution 50 ms. Func-
ional parameters and mass were determined by volumetric
maging. Imaging data were read using MASS software
version 4.2, Medis, Leiden, the Netherlands) at a single
eading center by readers trained in the MESA protocol and
ithout knowledge of risk factor information. Papillary
Abbreviations and Acronyms
CARDIA  Coronary Artery Risk Development in
Young Adults
HDL  high-density lipoprotein
ICC  intraclass correlation coefficient
LDL  low-density lipoprotein
LV  left ventricular
MESA  Multiethnic Study of Atherosclerosis
MRI  magnetic resonance imaginguscles were included in the LV volumes and excluded srom LV mass. Cardiac output was calculated as stroke
olume (end-diastolic volume  end-systolic volume) 
eart rate. Ejection fraction was calculated as stroke volume/
nd-diastolic volume. The reliability of the MRI readings
as determined by calculating for a set of 155 duplicate
eadings the intraclass correlation (ICC) as the ratio of the
ariance of the variable if precisely meaured (without mea-
urement error) over the observed variance of the variable
with measurement error). An ICC reliability estimate of
.95 means that 5% of the total variability is attributed to
eader measurement error. For LV mass, ICC was 0.97
95% confidence interval [CI] 0.96 to 0.98), for end-
iastolic volume 0.98 (95% CI 0.97 to 0.99), and for
nd-systolic volume 0.95 (95% CI 0.93 to 0.96).
tatistical analysis. We identified key variables that assess
raditional cardiovascular risk factors: systolic blood pres-
ure, diastolic blood pressure, tobacco use, alcohol use,
xercise (expressed as total MET-hours/week, where MET
s defined as the ratio of work metabolic rate to a standard
esting metabolic rate [10]), body mass index, LDL and
DL cholesterol, and glucose abnormalities. Participants
ere classified into 3 mutually exclusive categories regarding
lucose metabolism: those with a fasting glucose 126 mg/dl
r who used insulin or hypoglycemic agents were classified as
aving diabetes; nondiabetics with fasting glucose 100 and
126 mg/dl were classified as having impaired fasting glucose;
nd nondiabetics with fasting glucose 100 mg/dl were
lassified as normoglycemic (11). Risk factor data were
issing for 0.5% of participants for all variables except
lcohol use and LDL cholesterol, which were missing for
1.5% of participants.
We examined plots of the mean value of each MRI
easurement with levels of each risk factor after adjustment
or the sociodemographic characteristics of age, gender,
ace, and clinic location and adjustment for height as a
easure of body size. Linear relationships with all MRI
easurements were apparent for age, alcoholic drinks/week,
ody mass index, LDL and HDL cholesterol, and MET-
ours/week of exercise. For systolic and diastolic blood
ressure, we explored the possibility of nonlinear associa-
ions by including squared terms in the regression models.
mong the tobacco use categories, only current cigarette
moking was associated with the MRI measurements, and
herefore current smoking was modeled as a dichotomous
ariable.
We used multivariable linear regression to identify tradi-
ional cardiovascular risk factors independently associated
ith the cardiac MRI measurements; significance was
eclared at p  0.05. All of the risk factors were retained in
he models in addition to the sociodemographic variables
nd height. In a series of models, we introduced interaction
erms between each significant cardiovascular risk factor and
he sociodemographic variables of age (65 or 65 years),
ender, and race; significance for interactions was declared
t p 0.002 after Bonferroni correction for an average of 21
ubgroup comparisons per MRI measurement. In sensitivity
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December 5, 2006:2285–92 Cardiovascular Risk Factors and Cardiac MRInalyses, height squared (12) and height to the 2.7th power
13) were examined as alternatives to height as methods of
djustment for body size. Body surface area was not used to
djust for body size because obesity was of interest as a
raditional cardiovascular risk factor and adjustment for
ody surface area attenuates associations between obesity
nd LV mass. Waist circumference at the baseline exam and
elf-reported body mass index at ages 20 and 40 years were
xamined as alternatives to baseline body mass index as
easures of obesity. The association of systolic and diastolic
lood pressures with ejection fraction was examined across
respecified categories of blood pressure (14). All analyses
ere conducted using Stata Statistical Software release 8.0
Stata Corp., College Station, Texas). The analyses were
ased on the updated MESA database, which incorporated
inor corrections through November 2005.
ESULTS
f the 6,814 MESA participants, 5,004 (73%) completed
he cardiac MRI and had technically adequate data. Reasons
or not completing the cardiac MRI included ineligibility
7% out of 6,814), usually because of metallic fragment,
mplant, or device, inability (14%), usually because of
laustrophobia, refusal (3%), mechanical problem with the
canner (0.4%), or unknown (1%). Data on 1 or more
ardiovascular risk factors were missing for 135 participants
3%), and they were excluded. Compared with those not
ncluded in the analysis (n  1,945), the 4,869 participants
ncluded were on average slightly younger (62 vs. 64 years)
nd had lower average systolic blood pressure (125 vs. 130
m Hg) and body mass index (27.7 vs. 29.8 kg/m2); a
Table 1. Characteristics of 4,869 MESA Parti
in the Analysis
Age, yrs
Race, %
White
African American
Hispanic
Asian
High school graduate or less, %
Systolic BP, mm Hg
Diastolic BP, mm Hg
Hypertension,* %
Treated hypertension,† %
Current cigarette smoker, %
Alcohol use, drinks/week
Exercise, MET-h/wk
Body mass index, kg/m2
LDL cholesterol, mmol/l (mg/dl)
HDL cholesterol, mmol/l (mg/dl)
Use of lipid-lowering medication, %
Impaired fasting glucose, %
Diabetes, %
Values expressed as mean SD or percentage. *Hypertension
or with treated hypertension. †Treated hypertension was defi
antihypertensive medication.BP  blood pressure; HDL  high-density lipoprotein; LDL
imaging.maller proportion were African American (26% vs. 33%)
nd a larger proportion Asian (13% vs. 9%), and a smaller
roportion had treated hypertension (31% vs. 38%) or
iabetes (13% vs. 18%) (all differences significant at p 
.05). Among those included in the analysis, the mean age
as 62 years (SD 10), 52% were women, 39% white, 26%
frican American, 22% Hispanic, and 13% Asian (Table 1).
onsidering men and women together, 31% had treated
ypertension, 27% had impaired fasting glucose, and 13%
ad diabetes. Only 13% were current smokers, and the mean
umber of alcoholic drinks/week was 1.9 in women and 6.3
n men.
Data were available for all 4,869 participants for all 5
RI measurements of interest except cardiac output, which
as available for 4,850 participants. The gender-specific
eans and standard deviations of the MRI measurements
re shown in Table 2. For LV mass, the mean (SD)
xpressed in units of grams divided by height in meters was
7 (16) g/m in women and 97 (21) g/m in men.
The results from the 5 separate multivariable statistical
odels for the cardiac MRI measurements are shown in the
columns of Table 3. The first row of the table indicates the
roportion of the variability in each MRI measurement
xplained by the full model (including all the cardiovascular
isk factors, the sociodemographic variables, and height),
.e., the adjusted r2. The second row indicates the propor-
ion of the variability remaining after adjustment for socio-
emographic variables and height that was explained by the
ardiovascular risk factors. Below, the coefficients and 95%
I listed for each risk factor express the mean difference in
ach MRI measurement associated with that risk factor after
ts With Cardiac MRI Included
en (n  2,546) Men (n  2,323)
61 (10) 62 (10)
39.2 38.9
26.8 24.6
21.1 23.2
12.9 13.3
37.8 30.3
126 (23) 125 (19)
69 (10) 75 (9)
43.3 40.6
32.8 28.8
11.0 14.5
1.9 (5.1) 6.3 (10.8)
3.4 (33.8) 30.2 (44.3)
8.0 (5.6) 27.4 (4.1)
0.8) [117 (32)] 3.0 (0.8) [117 (31)]
0.4) [57 (15)] 1.2 (0.3) [45 (12)]
16.4 14.6
22.2 31.6
11.4 14.0
efined as BP140 mm Hg systolic or90 mm Hg diastolic,
a history of a physician diagnosis of hypertension and takingcipan
Wom
2
2
3.0 (
1.5 (
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Cardiovascular Risk Factors and Cardiac MRI December 5, 2006:2285–92djustment for all of the other cardiovascular risk factors in
he model, the sociodemographic variables, and height. For
ontinuous variables, such as blood pressure, the associa-
ions with MRI measurements are expressed in standard
eviation units. For example, for each standard deviation
21 mm Hg) increase in systolic blood pressure, the mean
V mass was 9.6 g greater (95% CI 8.5 to 10.8). A term for
he square of systolic blood pressure was included only in
he models for ejection fraction and cardiac output; diastolic
lood pressure squared was included only in the model for
jection fraction.
V mass. The LV mass was directly related to systolic
lood pressure, current smoking, exercise, body mass index,
nd diabetes after adjustment for the other variables in the
odel and was weakly inversely related to LDL cholesterol
Table 3). After adjustment for the sociodemographic vari-
bles and height, the proportion of the remaining variability
n LV mass explained by the cardiovascular risk factors was
6.1%.
Although risk factor relationships with LV mass were
enerally similar across subgroups defined by age, gender,
nd race, the associations with elevated systolic blood
ressure were more prominent in men than in women
13.5 vs. 6.9 g per standard deviation of systolic blood
ressure; p  0.0005) and in participants under 65 years of
ge than in those 65 and older (12.9 vs. 7.2 g per
tandard deviation of systolic blood pressure; p  0.0005),
nd the association with body mass index was stronger in
en than in women (15.0 vs. 10.5 g per standard
eviation of body mass index; p  0.0005).
V end-diastolic volume. The LV end-diastolic volume
as directly related to systolic blood pressure, exercise, body
ass index, and HDL cholesterol level and inversely related
o diastolic blood pressure, LDL cholesterol level, impaired
asting glucose, and diabetes after adjustment for the other
ariables in the model. The proportion of the remaining
ariability in LV end-diastolic volume after adjustment for
he sociodemographic variables and height that was ex-
lained by the cardiovascular risk factors was 12.2%. Rela-
ionships were similar across subgroups defined by age,
able 2. Gender-Specific Mean and Standard Deviation
f LV Mass, End-Diastolic Volume, Stroke Volume,
jection Fraction, and Cardiac Output by Cardiac MRI in
ESA Participants
Women
(n  2,546*)
Men
(n  2,323†)
Mean SD Mean SD
V mass (g) 124 27 169 37
V end-diastolic volume (ml) 114 24 140 33
V stroke volume (ml) 81 17 93 21
V ejection fraction (%) 71 7 67 7
ardiac output*† (l/min) 5.4 1.4 6.0 1.5
n  2,536 for cardiac output only. †n  2,314 for cardiac output only.
LV  left ventricular; MRI  magnetic resonance imaging.ender, and race. Ta
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V stroke volume were similar to those for end-diastolic
olume. Like end-diastolic volume, after adjustment for the
ther variables in the model, stroke volume was directly
elated to systolic blood pressure, exercise, body mass index,
nd HDL cholesterol and inversely related to diastolic blood
ressure, LDL cholesterol, impaired fasting glucose, and
iabetes. In addition, stroke volume was inversely related to
urrent smoking. After adjustment for the sociodemo-
raphic variables and height, the proportion of variability in
V stroke volume explained by the cardiovascular risk
actors was 14.5%.
Associations were similar in subgroups defined by gender
nd race, but the inverse association with diastolic blood
ressure was more prominent in participants 65 and older
han in those under 65 years of age (5.1 vs. 3.7 ml per
tandard deviation of diastolic blood pressure; p  0.001).
V ejection fraction. Ejection fraction was directly related
o systolic blood pressure and inversely related to diastolic
lood pressure, current smoking, and diabetes, after adjust-
ent for the other variables in the model. The coefficients
or the square of systolic and the square of diastolic blood
ressure were negative. These findings suggest that ejection
raction was directly related to systolic blood pressure except
t the highest levels of systolic blood pressure, where an
nverse relationship was seen, and that ejection fraction was
nversely related to diastolic blood pressure throughout the
ange of values, especially at the highest levels of diastolic
lood pressure. The results from these models were consis-
ent with plots of mean ejection fraction by categories of
ystolic (Fig. 1A) and diastolic blood pressure (Fig. 1B)
djusted for all of the other variables in the multivariable
odel. Only 2.4% of the remaining variability in ejection
raction was explained by the cardiovascular risk factors
onsidered after adjustment for the sociodemographic vari-
bles and height (Table 3).
Risk factor relationships with ejection fraction were
imilar in age, gender, and race subgroups. The relation-
hips of ejection fraction with systolic and diastolic blood
ressure levels were similar in users and nonusers of anti-
ypertensive medications, but mean ejection fraction was
igher at any given level of systolic or diastolic blood
ressure in those with medically treated hypertension than
n those with untreated hypertension.
ardiac output. Cardiac output was directly related to
ystolic blood pressure, body mass index, and HDL choles-
erol and inversely related to the square of systolic blood
ressure, current smoking, and LDL cholesterol after ad-
ustment for the other variables in the model. For systolic
lood pressure, these results suggest a positive relationship
t most levels of systolic blood pressure, but lower mean
ardiac output at the highest levels. After adjustment for the
ociodemographic variables and height, the proportion of
he remaining variability in cardiac output explained by the
ardiovascular risk factors was 11.2%. Relationships were
imilar across gender and race subgroups; the positive linear association with systolic blood pressure was stronger in
articipants under 65 than in those 65 years and older
0.29 vs. 0.21 l/min per standard deviation of systolic
lood pressure; p  0.001).
The inclusion of serum creatinine or educational status in
he models did not materially change the coefficients for the
isk factors listed in Table 3. In models where adjustment
or height was replaced with adjustment for height squared
r height to the 2.7th power, the coefficients associated with
he cardiovascular risk factors were virtually identical to
hose presented in Table 3. In models where systolic and
iastolic blood pressure were replaced with pulse pressure,
ulse pressure was strongly and positively associated with all
f the MRI measurements. For all MRI measurements,
elationships with current body mass index were similar to
elationships with body mass index at age 40 years and
lightly stronger than relationships with body mass index at
ge 20 years. The relationship of waist measurement with
he MRI measurements was similar to that of body mass
ndex. The associations of LDL cholesterol levels with the
RI measurements studied were slightly but not signifi-
antly weaker in users than in nonusers of lipid-lowering
igure 1. Adjusted mean ejection fraction (with standard error) for various
evels of systolic (A) and diastolic (B) blood pressure.gents. Among diabetics, the duration of use of diabetes
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ther measurements. Among ever smokers, pack-years of
igarette smoking was inversely related to end-diastolic
olume and stroke volume after adjustment for current
moking. Among participants with hypertension, the asso-
iations of cardiovascular risk factors with each of the MRI
easurements were similar in those taking and those not
aking antihypertensive medications.
ISCUSSION
n this cohort free of clinical cardiovascular disease, modi-
able cardiovascular risk factors were associated with sub-
linical alterations in LV mass, volumes, and systolic func-
ion as determined by cardiac MRI. After adjustment for
ociodemographic variables and height, higher systolic
lood pressure and body mass index were associated, as
xpected, with higher LV mass and larger volumes. In the
ormotensive range and up through systolic blood pressures
f 179 mm Hg, ejection fraction was directly related to
ystolic blood pressure, but at systolic blood pressures of
180 mm Hg, an inverse relationship was observed. By
ontrast, the higher the diastolic blood pressure, the lower
he ejection fraction, with a particularly low average ejection
raction at the highest levels of diastolic blood pressure.
urrent smoking and diabetes were associated with higher
V mass but lower stroke volume and ejection fraction, and
igh HDL cholesterol was associated with higher stroke
olume and cardiac output. Some associations with cardio-
ascular risk factors were more prominent in men than in
omen and differed in older compared with younger par-
icipants, but associations of risk factors with MRI mea-
urements did not differ significantly across racial/ethnic
roups.
The accuracy and reproducibility of cardiac MRI permit-
ed us to identify relationships of cardiovascular risk factors
ith subclinical alterations in LV size and systolic function
hat have been difficult to detect using previously available
oninvasive methods. The reproducibility of the MRI
easurements compared favorably with other large popula-
ion studies that used echocardiography. For example, in the
ARDIA (Coronary Artery Risk Development in Young
dults) study, the technical error of measurement for
eading LV mass ranged from 8% to 14% (1), and in
ESA, as calculated from the same 155 duplicate readings
escribed in the Methods section, it was 6.17% (95% CI
.29 to 7.04). The large sample size in this study allowed the
etection of very small differences in mass, volumes, and
ystolic function in relation to risk factors. These small
ifferences may be of little clinical significance to the
ndividual. However, if these differences persist and accu-
ulate over time, they could lead to clinically important
lterations in LV size or systolic function, and on a
opulation level such changes may assume public health
mportance. In addition, the accuracy of this method makes it suitable to follow the effects of treatments such as blood
ressure-lowering medications in individuals over time.
Strengths of this study include the representation of
everal ethnic groups and both genders, a wide age range, a
road range of levels of most cardiovascular risk factors, and
ecruitment from 6 geographically distinct areas of the U.S.
xtensive information on cardiovascular risk factors was
vailable, and the reliability of the MRI readings was
xcellent. Nonetheless, there was a limited range of levels of
ertain cardiovascular risk factors, including alcohol intake
nd exercise, limiting our ability to assess their relationships
ith cardiac size and function. The MRI exams were not
one on 27% of the participants, and those with an MRI
xam had on average fewer cardiovascular risk factors than
hose without an exam. The MESA cohort includes only
eople without clinically manifest cardiovascular disease; the
ssociations described here may differ from those in popu-
ations with clinically evident disease. Finally, because we
ad only a single cardiac MRI examination, we were not
ble to examine the longitudinal association of risk factors
ith change in LV geometry and systolic function.
The strong positive association of body mass index with
V mass and volumes was expected and may reflect both the
arger ventricular size required for greater lean body mass
nd a component related to adiposity. We were not able to
easure lean body mass and fat mass accurately with the
easurements of body size available in this study and
herefore were not able to determine the extent to which the
igher LV mass, volumes, and cardiac output seen with
igher body mass index are due to greater lean body mass
ersus excess adiposity. Indexation of each of the MRI
easurements by height and weight in healthy nonobese
ndividuals may allow better insight into the relationship of
diposity with LV geometry and function.
Our findings for risk factor associations with LV mass are
n general agreement with the echocardiographic findings
rom the CARDIA study (1) and the Cardiovascular Health
tudy (2). In one or both of these studies, LV mass was
irectly associated with weight, systolic blood pressure,
urrent smoking, and history of hypertension and was
nversely associated with diastolic blood pressure. Similar
ndings by echocardiography were reported from 2 Euro-
ean studies of men: a study of 475 men from the general
opulation of Uppsala County, Sweden (15), and a French
tudy of 843 healthy men 47 to 61 years of age (16). In the
rench study, body mass index at age 20 years was a stronger
eterminant of LV mass than current body mass index,
hereas in the present study current body mass index was
ore strongly associated with LV mass. In the Uppsala
tudy, elevated LDL/HDL cholesterol ratio at baseline was
ssociated with the development of LV hypertrophy 20
ears later (15), whereas in MESA high LDL was associ-
ted cross-sectionally with slightly lower LV mass. Unlike
he present analysis, the Uppsala study did not consider the
oint contributions of a variety of cardiovascular risk factors
n a multivariable model; this difference in analytic methods
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irect association of fasting insulin and triglyceride levels
ith LV hypertrophy was found in men only in an unad-
usted analysis of data from normotensive participants in the
ecumseh study (17), but in a multivariable analysis includ-
ng other cardiovascular risk factors neither of these associ-
tions persisted. By contrast, in multivariable analyses in
ESA, diabetes was associated with greater LV mass in
oth men and women, and diabetes and/or glucose intoler-
nce was associated with reduced end-diastolic volume,
troke volume, and ejection fraction.
Associations of potentially modifiable risk factors with
V mass are important because LV mass is a strong
redictor of sudden cardiac death (18), cardiovascular dis-
ase (19), and all-cause mortality in both middle-aged (20)
nd elderly individuals (21). A graded relationship with
ardiovascular morbidity and all-cause mortality throughout
he range of observed values for LV mass has been demon-
trated in people with hypertension (22,23), and lower LV
ass during antihypertensive treatment has been associated
ith lower risk of cardiovascular end points independent of
he extent of blood pressure-lowering (24). Furthermore,
linical trials suggest that in people with hypertension,
ong-term antihypertensive therapy may reduce LV mass as
easured by echocardiography (25,26) and that weight loss
esults in reduction in LV mass (27). Whether treatment of
ther risk factors, such as smoking and diabetes, would
esult in reduction of LV mass is not clear but may become
menable to study through the use of cardiac MRI.
In contrast to LV mass, there is considerably less infor-
ation on the associations of cardiovascular risk factors with
V volumes or systolic function in populations without
ecognized cardiovascular disease. Despite the known acute
ffects of nicotine to increase heart rate and contractility,
troke volume, ejection fraction, and cardiac output were on
verage slightly lower in the present study in current
mokers than in nonsmokers. The mechanisms underlying
hese observations and the observed associations of high
DL cholesterol and low LDL cholesterol with higher
olumes and cardiac output require further study.
In summary, in this cohort free of clinical cardiovascular
isease, modifiable risk factors were associated with subclin-
cal alterations in LV size and systolic function. The
roportion of variability within all the cardiac MRI mea-
urements explainable by traditional cardiac risk factors was
mall, however, and this was particularly true for ejection
raction. The high degree of reproducibility of cardiac MRI
hould allow the detection of subtle deterioration or im-
rovement in LV size and function. Additional study is
eeded of risk factors and their treatment in relation to the
ew development or progression of LV dysfunction and of
he relationship of subclinical alterations of cardiac size and
unction with outcomes such as myocardial infarction and
udden cardiac death. Longitudinal study of the MESA
ohort and other cohorts may provide important informa-
ion in this regard.cknowledgments
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